Dissemin is shutting down on January 1st, 2025

Published in

American Association for the Advancement of Science, Science Translational Medicine, 120(4), 2012

DOI: 10.1126/scitranslmed.3003728

Links

Tools

Export citation

Search in Google Scholar

Escaping ALK Inhibition: Mechanisms of and Strategies to Overcome Resistance

Journal article published in 2012 by Christine M. Lovly ORCID, William Pao
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Two recent studies offer insights on how cancer cells develop resistance to targeted therapies and possible ways to battle this therapeutic bottleneck.